查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279870

2023-2030年全球CAR T細胞療法市場規模研究與預測，按適應症、藥物類型、終端用戶和區域分析。

Global CAR T-Cell therapy Market Size study & Forecast, by Indication, By Drug Type, By End user, and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2022年全球CAR T細胞療法市場價值約為19.3億美元，預計在2023-2030年預測期內將以超過13.5%的健康成長率成長。嵌合抗原受體（CAR）T細胞療法是一種新型的癌症療法，醫學專家在實驗室裡對T細胞進行改造，然後再將其注射到癌症患者的體內，使其能夠檢測和消除癌細胞。透過CAR T細胞療法，免疫系統訓練識別惡性細胞。透過CAR T細胞治療，針對惡性細胞的免疫反應增強。驅動CAR T細胞療法市場的主要因素是對治療癌症的合適療法的需求增加，一些國家對CAR T細胞療法藥物的有利支付政策，以及消費者對CAR T細胞療法藥物的認識增加。此外，最近CAR-T細胞療法的商業化和臨床試驗活動的激增，也進一步影響了市場的擴張。

此外，白血病和淋巴瘤等癌症發病率的增加也直接增加了對CAR T細胞療法的需求。根據世界衛生組織（WHO）的資料，2020年，白血病癌症病例估計為47.5萬，預計到2040年將達到69.2萬患者。因此，癌症發病率的成長推動對廣泛的診斷和治療方案的需求，這又加速了CAR T細胞療法市場的成長。此外，在研究和開發方面的投資不斷增加，以及技術的不斷進步，在預測的幾年裡呈現出各種有利的機會。然而，在2023-2030年的預測期內，缺乏熟練的專業人員和開發CAR T細胞療法的高成本挑戰市場成長。

全球CAR T細胞療法市場研究涵蓋的主要地區包括亞太、北美、歐洲、拉丁美洲、中東和非洲。北美在2022年佔據了市場的主導地位，這是因為監管部門的批准不斷增加，對先進的醫療設施的投資不斷增加，以及技術發展不斷上升。而亞太地區預計將在預測的幾年里以最高的年複合成長率成長。癌症發病率的上升，政府機構對新型療法研究資金的增加，以及對新型藥物的認識和批准的增加，都大幅推動了整個地區的市場需求。

該研究的目的是確定近年來不同領域和國家的市場規模，並預測未來幾年的價值。本報告旨在將研究涉及的國家內的產業的定性和定量方面都涵蓋其中。

本報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來成長。此外，還涵蓋了微觀市場的潛在機會，供利益相關者投資，並詳細分析了競爭格局和主要參與者的產品。

目錄

第一章：執行摘要

  • 市場簡介
  • 2020-2030年全球及細分市場的估計和預測
    • 2020-2030年，CAR T細胞治療市場，按地區分類
    • 2020-2030年，CAR T細胞療法市場，按適應症分類
    • 2020-2030年，CAR T細胞療法市場，按藥物類型分類
    • 2020-2030年，CAR T細胞療法市場，按終端用戶分類
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球CAR T細胞療法市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 產業演變
    • 研究的範圍
  • 研究涵蓋的年份
  • 貨幣轉換率

第三章：全球CAR T-細胞療法市場動態

  • CAR T細胞療法的市場影響分析（2020-2030）。
    • 市場驅動力
      • 白血病和淋巴瘤等癌症的發病率增加
      • 對CAR T細胞療法藥物的有利支付政策
    • 市場挑戰
      • 無法獲得熟練的專業人員
      • 開發CAR T細胞療法的成本高
    • 市場機會
      • 研究和開發的投資不斷增加
      • 技術的不斷進步

第四章：全球CAR T細胞療法市場產業分析

  • 波特的5力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力影響分析
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術
    • 環境
    • 法律問題
  • 最佳投資機會
  • 最佳策略
  • COVID-19影響分析
  • 顛覆性趨勢
  • 產業專家的觀點
  • 分析師建議與結論

第五章：全球CAR T細胞治療市場，按適應症分類

  • 市場簡介
  • 全球CAR T細胞療法市場，按適應症、性能- 潛力分析
  • 2020-2030年全球CAR T細胞治療市場按適應症的估計和預測
  • CAR T細胞療法市場，細項分析
    • 淋巴瘤
    • 急性淋巴細胞白血病
    • 其他疾病

第六章：全球CAR T細胞療法市場，按藥物類型分類

  • 市場簡介
  • 全球CAR T細胞療法市場，按藥物類型，性能-潛力分析
  • 2020-2030年全球CAR T細胞治療市場按藥物類型的估計和預測
  • CAR T細胞療法市場，細項分析
    • Axicabtagene Ciloleucel
    • Tisagenlecleucel
    • Brexucabtagene Autoleucel
    • 其他

第7章：全球CAR T細胞治療市場，按終端用戶分類

  • 市場簡介
  • 全球CAR T細胞療法市場，按終端用戶，性能-潛力分析
  • 2020-2030年全球CAR T細胞治療市場按終端用戶的估計和預測
  • CAR T-細胞療法市場，細項分析
    • 醫院
    • 癌症治療中心

第八章：全球CAR T-細胞療法市場，區域分析

  • 最領先的國家
  • 新興國家
  • CAR T細胞療法市場，區域市場簡介
  • 北美洲
    • 美國
      • 適應症分類估計和預測，2020-2030年
      • 2020-2030年藥物類型分類估計和預測
      • 2020-2030年終端用戶分類估計和預測
    • 加拿大
  • 歐洲CAR T細胞療法市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區CAR T細胞治療市場簡介
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太其他地區
  • 拉丁美洲CAR T細胞療法市場概況
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第九章：競爭情報

  • 主要公司SWOT分析
    • 公司1
    • 公司2
    • 公司3
  • 頂級市場戰略
  • 公司簡介
    • Autolus Therapeutics
      • 關鍵資訊
      • 概況
      • 財務（取決於資料的可用性）
      • 產品摘要
      • 近期發展情況
    • Bluebird bio, Inc.
    • Bristol-Myers Squibb
    • Caribou Biosciences, Inc.
    • Cartesian Therapeutics, Inc.
    • Celgene Corporation
    • Gilead Sciences, Inc. (Kite Pharma Inc.)
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.

第十章：研究過程

  • 研究過程
    • 資料探勘
    • 資料分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimeric antigen receptor (CAR) T cell therapy is a novel form of cancer therapy in which medical experts modify T cells in a lab before injecting them into cancer patients' bodies to enable them to detect and eliminate cancer cells. The immune system is trained to recognize malignant cells by CAR T-cell therapy. The immune response against malignant cells is boosted by CAR T-cell treatment. The market for CAR T-cell therapy is primarily driven by an increase in the demand for suitable therapeutics for the treatment of cancer, favorable reimbursement policies for CAR T-cell therapy medications in some countries, and an increase in consumer awareness of CAR T-cell therapy medications. Additionally, the recent commercialization of CAR-T cell therapy and the surging clinical trial activities are further influencing the market expansion.

In addition, an increase in the incidence of cancer such as leukemia and lymphoma are directly augmenting the demand for CAR T-Cell therapy. According to World Health Organization (WHO), in 2020, the number of leukemia cancer cases is estimated to account for 475 thousand, which is projected to reach 692 thousand patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for a wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the CAR T-Cell therapy Market. Moreover, the growing investment in research and development, as well as increasing advancements in technology present various lucrative opportunities over the forecasting years. However, the unavailability of skilled professionals and the high cost of developing CAR T-cell therapy are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global CAR T-Cell therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing regulatory approvals, growing investment in advancing healthcare facilities, and rising technological developments. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising prevalence of cancer, increasing research funding for novel therapeutics by government bodies, and growing awareness and increase in approval of novel medications are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Autolus Therapeutics
  • Bluebird bio, Inc.
  • Bristol-Myers Squibb
  • Caribou Biosciences, Inc.
  • Cartesian Therapeutics, Inc.
  • Celgene Corporation
  • Gilead Sciences, Inc. (Kite Pharma Inc.)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.

Recent Developments in the Market:

  • In June 2022, Bristol-Myers Squibb Company announced that the company received the U.S. Food and Drug Administration (FDA) approval for Breyanzi CAR T cell therapy to cure refractory or relapsed large B-cell lymphoma after one prior therapy. The Phase 2 pilot company-sponsored research of a CAR T cell treatment in patients with primary refractory or relapsed LBCL served as the foundation for the approval.
  • In February 2022, Johnson & Johnson Services, Inc. declared that the U.S. Food and Drug Administration had approved CARVYKTI (ciltacabtagene autoleucel), a BCMA-Directed CAR-T Immunotherapy for the treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Global CAR T-Cell therapy Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Indication, Drug type, End user, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Indication:

  • Lymphoma
  • Acute Lymphocytic Leukemia
  • Others

By Drug type:

  • Axicabtagene Ciloleucel
  • Tisagenlecleucel
  • Brexucabtagene Autoleucel
  • Others

By End-user:

  • Hospitals
  • Cancer Treatment Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. CAR T-Cell therapy Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. CAR T-Cell therapy Market, by Indication, 2020-2030 (USD Billion)
    • 1.2.3. CAR T-Cell therapy Market, by Drug type, 2020-2030 (USD Billion)
    • 1.2.4. CAR T-Cell therapy Market, by End user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global CAR T-Cell therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global CAR T-Cell therapy Market Dynamics

  • 3.1. CAR T-Cell therapy Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the incidence of cancer such as leukemia and lymphoma
      • 3.1.1.2. Favorable reimbursement policies for CAR T-cell therapy medications
    • 3.1.2. Market Challenges
      • 3.1.2.1. Unavailability of skilled professionals
      • 3.1.2.2. High cost of developing CAR T-cell therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing investment in research and development
      • 3.1.3.2. Increasing advancements in technology

Chapter 4. Global CAR T-Cell therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global CAR T-Cell therapy Market, by Indication

  • 5.1. Market Snapshot
  • 5.2. Global CAR T-Cell therapy Market by Indication, Performance - Potential Analysis
  • 5.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
  • 5.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 5.4.1. Lymphoma
    • 5.4.2. Acute Lymphocytic Leukemia
    • 5.4.3. Others

Chapter 6. Global CAR T-Cell therapy Market, by Drug type

  • 6.1. Market Snapshot
  • 6.2. Global CAR T-Cell therapy Market by Drug type, Performance - Potential Analysis
  • 6.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Drug type 2020-2030 (USD Billion)
  • 6.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 6.4.1. Axicabtagene Ciloleucel
    • 6.4.2. Tisagenlecleucel
    • 6.4.3. Brexucabtagene Autoleucel
    • 6.4.4. Others

Chapter 7. Global CAR T-Cell therapy Market, by End user

  • 7.1. Market Snapshot
  • 7.2. Global CAR T-Cell therapy Market by End user, Performance - Potential Analysis
  • 7.3. Global CAR T-Cell therapy Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
  • 7.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Cancer Treatment Centers

Chapter 8. Global CAR T-Cell therapy Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. CAR T-Cell therapy Market, Regional Market Snapshot
  • 8.4. North America CAR T-Cell therapy Market
    • 8.4.1. U.S. CAR T-Cell therapy Market
      • 8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Drug type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada CAR T-Cell therapy Market
  • 8.5. Europe CAR T-Cell therapy Market Snapshot
    • 8.5.1. U.K. CAR T-Cell therapy Market
    • 8.5.2. Germany CAR T-Cell therapy Market
    • 8.5.3. France CAR T-Cell therapy Market
    • 8.5.4. Spain CAR T-Cell therapy Market
    • 8.5.5. Italy CAR T-Cell therapy Market
    • 8.5.6. Rest of Europe CAR T-Cell therapy Market
  • 8.6. Asia-Pacific CAR T-Cell therapy Market Snapshot
    • 8.6.1. China CAR T-Cell therapy Market
    • 8.6.2. India CAR T-Cell therapy Market
    • 8.6.3. Japan CAR T-Cell therapy Market
    • 8.6.4. Australia CAR T-Cell therapy Market
    • 8.6.5. South Korea CAR T-Cell therapy Market
    • 8.6.6. Rest of Asia Pacific CAR T-Cell therapy Market
  • 8.7. Latin America CAR T-Cell therapy Market Snapshot
    • 8.7.1. Brazil CAR T-Cell therapy Market
    • 8.7.2. Mexico CAR T-Cell therapy Market
  • 8.8. Middle East & Africa CAR T-Cell therapy Market
    • 8.8.1. Saudi Arabia CAR T-Cell therapy Market
    • 8.8.2. South Africa CAR T-Cell therapy Market
    • 8.8.3. Rest of Middle East & Africa CAR T-Cell therapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Autolus Therapeutics
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bluebird bio, Inc.
    • 9.3.3. Bristol-Myers Squibb
    • 9.3.4. Caribou Biosciences, Inc.
    • 9.3.5. Cartesian Therapeutics, Inc.
    • 9.3.6. Celgene Corporation
    • 9.3.7. Gilead Sciences, Inc. (Kite Pharma Inc.)
    • 9.3.8. Merck & Co., Inc.
    • 9.3.9. Novartis AG
    • 9.3.10. Pfizer, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global CAR T-Cell therapy Market, report scope
  • TABLE 2. Global CAR T-Cell therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global CAR T-Cell therapy Market estimates & forecasts by Indication 2020-2030 (USD Billion)
  • TABLE 4. Global CAR T-Cell therapy Market estimates & forecasts by Drug type 2020-2030 (USD Billion)
  • TABLE 5. Global CAR T-Cell therapy Market estimates & forecasts by End user 2020-2030 (USD Billion)
  • TABLE 6. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global CAR T-Cell therapy Market
  • TABLE 71. List of primary sources, used in the study of global CAR T-Cell therapy Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global CAR T-Cell therapy Market, research methodology
  • FIG 2. Global CAR T-Cell therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global CAR T-Cell therapy Market, key trends 2022
  • FIG 5. Global CAR T-Cell therapy Market, growth prospects 2023-2030
  • FIG 6. Global CAR T-Cell therapy Market, porters 5 force model
  • FIG 7. Global CAR T-Cell therapy Market, pest analysis
  • FIG 8. Global CAR T-Cell therapy Market, value chain analysis
  • FIG 9. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global CAR T-Cell therapy Market, regional snapshot 2020 & 2030
  • FIG 15. North America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa CAR T-Cell therapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable